Authors: Gharat, L Taneja, R Weerapreeyakul, N Rege, B Polli, J Chikhale, PJ

Citation: L. Gharat et al., Targeted drug delivery systems 6. Intracellular bioreductive activation, uptake and transport of an anticancer drug delivery system across intestinalCaco-2 cell monolayers, INT J PHARM, 219(1-2), 2001, pp. 1-10

Authors: Killian, DM Chikhale, PJ

Citation: Dm. Killian et Pj. Chikhale, Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature, NEUROSCI L, 306(1-2), 2001, pp. 1-4

Authors: Killian, DM Chikhale, PJ

Citation: Dm. Killian et Pj. Chikhale, A bioreversible prodrug approach designed to shift mechanism of brain uptake for amino-acid-containing anticancer agents, J NEUROCHEM, 76(4), 2001, pp. 966-974

Authors: Weerapreeyakul, N Visser, P Brummelhuis, M Gharat, L Chikhale, PJ

Citation: N. Weerapreeyakul et al., Reductive and bioreductive activation is controlled by electronic properties of substituents in conformationally-constrained anticancer drug deliverysystems, MED CHEM RE, 10(3), 2000, pp. 149-163

Authors: Weerapreeyakul, N Hollenbeck, RG Chikhale, PJ

Citation: N. Weerapreeyakul et al., Stability of bioreductive drug delivery systems containing melphalan is influenced by conformational constraint and electronic properties of substituents, BIOORG MED, 10(21), 2000, pp. 2391-2395